Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Global X Genomics & Biotechnology UCITS ETF
ISIN IE00BM8R0N95
|Ticker GNOM
TER
0.50% p.a.
Distribution policy
Accumulating
Replication
Physical
Fund size
EUR 19 m
Inception Date
2 November 2021
Holdings
50
Overview
Description
The Global X Genomics & Biotechnology UCITS ETF seeks to track the Solactive Genomics index. The Solactive Genomics index tracks companies active in the fields of genomics and biotechnology.
Chart
Basics
Data
| Index | Solactive Genomics |
| Investment focus | Aandelen, Wereld, Gezondheidszorg |
| Fund size | EUR 19 m |
| Total expense ratio | 0,50% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 40,10% |
| Inception/ Listing Date | 2 november 2021 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ierland |
| Fund Provider | Global X |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | SEI Investments – Global Fund Services Limited |
| Investment Advisor | |
| Custodian Bank | Brown Brothers Harriman & Co. |
| Revision Company | PwC |
| Fiscal Year End | - |
| Swiss representative | 1741 Fund Solutions AG |
| Swiss paying agent | Tellco AG |
| Germany | 30% belastingvermindering |
| Switzerland | ESTV Reporting |
| Austria | Belastingrapportagefonds |
| UK | UK-rapportage |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
Similar ETFs
This section provides you with information on other ETFs with a similar investment focus to the Global X Genomics & Biotechnology UCITS ETF.
Similar ETFs via investment guides
How do you like our ETF profile? Here you'll find our Questionnaire.
Holdings
Below you find information about the composition of the Global X Genomics & Biotechnology UCITS ETF.
Top 10 Holdings
Weight of top 10 holdings
out of 50
43,96%
| Guardant Health, Inc. | 5,65% |
| Illumina, Inc. | 5,21% |
| Arrowhead Pharmaceuticals | 4,93% |
| Natera | 4,67% |
| BioMarin Pharmaceutical | 4,07% |
| Moderna, Inc. | 3,97% |
| Bio-Techne | 3,90% |
| Vertex Pharmaceuticals | 3,90% |
| Avidity Biosciences | 3,86% |
| QIAGEN | 3,80% |
Countries
| Verenigde Staten | 73,87% |
| Duitsland | 3,50% |
| Zwitserland | 3,18% |
| Verenigd Koninkrijk | 2,12% |
| Anders | 17,33% |
Sectors
| Gezondheidszorg | 87,35% |
| Anders | 12,65% |
As of 31/12/2025
Performance
Returns overview
| YTD | -0.43% |
| 1 month | -1.43% |
| 3 months | -2.82% |
| 6 months | +20.67% |
| 1 year | +16.19% |
| 3 years | -18.65% |
| 5 years | - |
| Since inception (MAX) | -49.30% |
| 2025 | +5.17% |
| 2024 | -10.84% |
| 2023 | -11.72% |
| 2022 | -32.85% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 40.10% |
| Volatility 3 years | 33.24% |
| Volatility 5 years | - |
| Return per risk 1 year | 0.40 |
| Return per risk 3 years | -0.20 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -24.11% |
| Maximum drawdown 3 years | -47.18% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -67.11% |
Rolling 1 year volatility
Stock exchange
Listings
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Borsa Italiana | EUR | GNOM | - - | - - | - |
| gettex | EUR | GN0M | - - | - - | - |
| Bourse de Francfort | EUR | - | GHCO/Virtu | ||
| Borsa Italiana | EUR | - | GNOMEUIV | GNOM.MI | GHCO/Virtu |
| London Stock Exchange | USD | GNOM | GNOM LN GNOMUSIV | GNOM.L GNOMiv.P | GHCO/Virtu |
| London Stock Exchange | GBP | GNOG | GNOG LN GNOMGBIV | GNOG.L | GHCO/Virtu |
| SIX Swiss Exchange | CHF | GNOM | GNOMCHIV | GNOM.S | GHCO/Virtu |
| XETRA | EUR | GN0M | GNOMEUIV | GN0M.DE | GHCO/Virtu |
Plus d'informations
Guides d'investissement intéressants pour les ETF
Latest articles
Frequently asked questions
What is the name of GNOM?
The name of GNOM is Global X Genomics & Biotechnology UCITS ETF.
What is the ticker of Global X Genomics & Biotechnology UCITS ETF?
The primary ticker of Global X Genomics & Biotechnology UCITS ETF is GNOM.
What is the ISIN of Global X Genomics & Biotechnology UCITS ETF?
The ISIN of Global X Genomics & Biotechnology UCITS ETF is IE00BM8R0N95.
What are the costs of Global X Genomics & Biotechnology UCITS ETF?
The total expense ratio (TER) of Global X Genomics & Biotechnology UCITS ETF amounts to 0,50% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is Global X Genomics & Biotechnology UCITS ETF paying dividends?
Global X Genomics & Biotechnology UCITS ETF is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of Global X Genomics & Biotechnology UCITS ETF?
The fund size of Global X Genomics & Biotechnology UCITS ETF is 19m Euro. See the following article for more information about the size of ETFs.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.